Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children
Clinical trial NCT00985790 · COMPLETED
Trial details
- NCT number
- NCT00985790
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-08
- Primary completion
- 2010-05-21
- Enrollment
- 599
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.